And although AbbVie managed to get Zinbryta (daclizumab) on the market with partner Biogen for multiple sclerosis, earlier this year the companies withdrew it because of a risk of serious brain ...

Adeno-associated viruses (AAV) have emerged as the lead vector in clinical trials and form the basis for several approved gene therapies for human diseases, mainly owing to their ability to sustain ...

Breast cancer is one of the most frequent cancer types worldwide and the first cause of cancer-related deaths in women. Although significant therapeutic advances have been achieved with drugs such as ...